Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

788 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pertussis.
Gabutti G, Azzari C, Bonanni P, Prato R, Tozzi AE, Zanetti A, Zuccotti G. Gabutti G, et al. Among authors: zuccotti g. Hum Vaccin Immunother. 2015;11(1):108-17. doi: 10.4161/hv.34364. Epub 2014 Nov 1. Hum Vaccin Immunother. 2015. PMID: 25483523 Free PMC article. Review.
Long-term immunogenicity after one and two doses of a monovalent MF59-adjuvanted A/H1N1 Influenza virus vaccine coadministered with the seasonal 2009-2010 nonadjuvanted Influenza virus vaccine in HIV-infected children, adolescents, and young adults in a randomized controlled trial.
Viganò A, Giacomet V, Pariani E, Giani E, Manfredini V, Bedogni G, Erba P, Amendola A, Zanetti A, Zuccotti G. Viganò A, et al. Among authors: zuccotti g. Clin Vaccine Immunol. 2011 Sep;18(9):1503-9. doi: 10.1128/CVI.05200-11. Epub 2011 Jul 27. Clin Vaccine Immunol. 2011. PMID: 21795458 Free PMC article. Clinical Trial.
New insights into rotavirus vaccines.
Mameli C, Fabiano V, Zuccotti GV. Mameli C, et al. Hum Vaccin Immunother. 2012 Aug;8(8):1022-8. doi: 10.4161/hv.20295. Epub 2012 Aug 1. Hum Vaccin Immunother. 2012. PMID: 22699445 Free PMC article. Review.
The immunogenicity and safety of a single 0.5 mL dose of virosomal subunit influenza vaccine administered to unprimed children aged ≥6 to <36 months: data from a randomized, Phase III study.
Esposito S, Marchisio P, Montinaro V, Bianchini S, Weverling GJ, Pariani E, Amendola A, Fabiano V, Pivetti V, Zanetti A, Zuccotti GV. Esposito S, et al. Vaccine. 2012 Nov 19;30(49):7005-12. doi: 10.1016/j.vaccine.2012.09.069. Epub 2012 Oct 8. Vaccine. 2012. PMID: 23059357 Clinical Trial.
Risk of cervical HPV infection and prevalence of vaccine-type and other high-risk HPV types among sexually active teens and young women (13-26 years) enrolled in the VALHIDATE study.
Orlando G, Fasolo M, Mazza F, Ricci E, Esposito S, Frati E, Zuccotti GV, Cetin I, Gramegna M, Rizzardini G, Tanzi E; Valhidate Study Group. Orlando G, et al. Among authors: zuccotti gv. Hum Vaccin Immunother. 2014;10(4):986-94. doi: 10.4161/hv.27682. Epub 2014 Jan 15. Hum Vaccin Immunother. 2014. PMID: 24423757 Free PMC article.
788 results